Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2026-01-09 @ 2:21 AM
Study NCT ID:
NCT03913234
Status:
UNKNOWN
Last Update Posted:
2022-05-10
First Post:
2019-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
Sponsor:
Yonsei University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-10
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-04-10
First Submit QC Date:
None
Study First Post Date:
2019-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-09
Last Update Post Date:
2022-05-10
Last Update Post Date Type:
ACTUAL